Diagnosis and treatment of metastatic and castration resistant prostate cancer became more and more and complex due to the increasing knowledge and understanding of the underlying molecular events and the subsequently deducted innovative medical treatment
Modern imaging studies in CRPCA have become more and more complex and selective and currently include positron emission tomography, whole body magnetic resonance imaging, immunoscintigraphy besides the traditional studies such as bone scans and computed tomography.
About the Editors
Kurt Miller MD, PhD
Professor Miller has been Chairman and Professor of Urology for the Department of Urology at the Benjamin Franklin Medical Center, Berlin, Germany, since 1993. In 2007 he became Chairman of the ...
Read more »
Axel Merseburger MD, PhD
Prof Axel S. Merseburger is currently Vice Chairman of the Department of Urologic Oncology, as well as Director of the Urologic Oncology Programme at Hannover Medical School, Germany. ...
Read more »
31 July - 2 August
MIBIE Summer School 2014 – Male Infertility Microbiology and Infl ammation in Urogenital Infections
Contact: Department of Urology, Pediatric Urology
and Andrology, University Hospital Giessen
Tel.: +49 641 985 44516
Fax: +49 641 985 44519
E-mail: fl firstname.lastname@example.org
14 August - 16 August
FAU National Congress of Urology
Rosario City, Argentina
Contact: Federación Argentina de Urología
Tel.: +54 351 468 3111
Fax: +54 351 468 3111
21 August - 23 August
7th International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer
Pasadena, CA, USA
Contact: Erasmus S.A.
Tel.: +30 210 7414718
Fax: +30 210 7257532